{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:25:45Z","timestamp":1787811945428,"version":"build-2784847793"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA098131"],"award-info":[{"award-number":["P50CA098131"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008900","name":"University of South Florida","doi-asserted-by":"crossref","award":["2018 COPH Faculty Research Award"],"award-info":[{"award-number":["2018 COPH Faculty Research Award"]}],"id":[{"id":"10.13039\/100008900","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ingram Professorship"},{"DOI":"10.13039\/100012394","name":"Kleberg Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012394","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Vanderbilt Genetic Institute","award":["Departmental Funds"],"award-info":[{"award-number":["Departmental Funds"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10549-020-05699-y","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T10:03:08Z","timestamp":1590141788000},"page":"421-428","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cancer risk management among female BRCA1\/2, PALB2, CHEK2, and ATM carriers"],"prefix":"10.1007","volume":"182","author":[{"given":"Deborah","family":"Cragun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Weidner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Tezak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Clouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8009-2475","authenticated-orcid":false,"given":"Tuya","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"5699_CR1","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66\u201371","journal-title":"Science"},{"key":"5699_CR2","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/378789a0","volume":"378","author":"R Wooster","year":"1995","unstructured":"Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789\u2013792. https:\/\/doi.org\/10.1038\/378789a0","journal-title":"Nature"},{"issue":"15","key":"5699_CR3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1200\/jco.18.01854","volume":"37","author":"AW Kurian","year":"2019","unstructured":"Kurian AW, Ward KC, Howlader N, Deapen D, Hamilton AS, Mariotto A, Miller D, Penberthy LS, Katz SJ (2019) Genetic testing and results in a population-based cohort of breast cancer patients and ovarian cancer patients. J Clin Oncol 37(15):1305\u20131315. https:\/\/doi.org\/10.1200\/jco.18.01854","journal-title":"J Clin Oncol"},{"issue":"31","key":"5699_CR4","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/jco.2015.63.0996","volume":"33","author":"ME Robson","year":"2015","unstructured":"Robson ME, Bradbury AR, Arun B, Domchek SM, Ford JM, Hampel HL, Lipkin SM, Syngal S, Wollins DS, Lindor NM (2015) American society of clinical oncology policy statement update: genetic and genomic testing for cancer susceptibility. J Clin Oncol 33(31):3660\u20133667. https:\/\/doi.org\/10.1200\/jco.2015.63.0996","journal-title":"J Clin Oncol"},{"issue":"6","key":"5699_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/nejmoa1706450","volume":"377","author":"M Robson","year":"2017","unstructured":"Robson M, Im SA, Senkus E, Xu B, Domchek SM, Masuda N, Delaloge S, Li W, Tung N, Armstrong A, Wu W, Goessl C, Runswick S, Conte P (2017) Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med 377(6):523\u2013533. https:\/\/doi.org\/10.1056\/nejmoa1706450","journal-title":"N Engl J Med"},{"issue":"8","key":"5699_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1001\/jamaoncol.2018.0644","volume":"4","author":"AW Kurian","year":"2018","unstructured":"Kurian AW, Ward KC, Hamilton AS, Deapen DM, Abrahamse P, Bondarenko I, Li Y, Hawley ST, Morrow M, Jagsi R, Katz SJ (2018) Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer. JAMA Oncol 4(8):1066\u20131072. https:\/\/doi.org\/10.1001\/jamaoncol.2018.0644","journal-title":"JAMA Oncol"},{"issue":"9","key":"5699_CR7","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jamaoncol.2017.0424","volume":"3","author":"FJ Couch","year":"2017","unstructured":"Couch FJ, Shimelis H, Hu C, Hart SN, Polley EC, Na J, Hallberg E, Moore R, Thomas A, Lilyquist J, Feng B, McFarland R, Pesaran T, Huether R, LaDuca H, Chao EC, Goldgar DE, Dolinsky JS (2017) Associations between cancer predisposition testing panel genes and breast cancer. JAMA Oncol 3(9):1190\u20131196. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0424","journal-title":"JAMA Oncol"},{"issue":"11","key":"5699_CR8","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1200\/jco.2006.09.1066","volume":"25","author":"S Chen","year":"2007","unstructured":"Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25(11):1329\u20131333. https:\/\/doi.org\/10.1200\/jco.2006.09.1066","journal-title":"J Clin Oncol"},{"issue":"5645","key":"5699_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646. https:\/\/doi.org\/10.1126\/science.1088759","journal-title":"Science"},{"issue":"23","key":"5699_CR10","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","volume":"317","author":"KB Kuchenbaecker","year":"2017","unstructured":"Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, McGuffog L, Evans DG, Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R, Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP, Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM, Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K, Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA, Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson H (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 317(23):2402\u20132416. https:\/\/doi.org\/10.1001\/jama.2017.7112","journal-title":"JAMA"},{"issue":"7","key":"5699_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1200\/jco.19.01907","volume":"38","author":"X Yang","year":"2020","unstructured":"Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittom\u00e4ki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg \u00c5, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, Pauw Ad, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Taib NAM, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylk\u00e4s K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte A-B, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, TvO H, Whitworth J, Wood M, Yip CH, Yoon S-Y, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balma\u00f1a J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, Nevanlinna H, Schmutzler R, Teo S-H, Robson M, Pal T, Couch F, Weitzel JN, Elliott A, Southey M, Winqvist R, Easton DF, Foulkes WD, Antoniou AC, Tischkowitz M (2020) Cancer risks associated with germline PALB2 pathogenic variants: an international study of 524 families. J Clin Oncol 38(7):674\u2013685. https:\/\/doi.org\/10.1200\/jco.19.01907","journal-title":"J Clin Oncol"},{"issue":"23","key":"5699_CR12","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/nejmsr1501341","volume":"372","author":"DF Easton","year":"2015","unstructured":"Easton DF, Pharoah PD, Antoniou AC, Tischkowitz M, Tavtigian SV, Nathanson KL, Devilee P, Meindl A, Couch FJ, Southey M, Goldgar DE, Evans DG, Chenevix-Trench G, Rahman N, Robson M, Domchek SM, Foulkes WD (2015) Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med 372(23):2243\u20132257. https:\/\/doi.org\/10.1056\/nejmsr1501341","journal-title":"N Engl J Med"},{"issue":"1","key":"5699_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2018.2956","volume":"5","author":"HM Lu","year":"2019","unstructured":"Lu HM, Li S, Black MH, Lee S, Hoiness R, Wu S, Mu W, Huether R, Chen J, Sridhar S, Tian Y, McFarland R, Dolinsky J, Tippin Davis B, Mexal S, Dunlop C, Elliott A (2019) Association of breast and ovarian cancers with predisposition genes identified by large-scale sequencing. JAMA Oncol 5(1):51\u201357. https:\/\/doi.org\/10.1001\/jamaoncol.2018.2956","journal-title":"JAMA Oncol"},{"key":"5699_CR14","unstructured":"National Comprehensive Cancer Network (NCCN) (2020) Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic V.1.2020. NCCN practice guidelines website. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf. Accessed 4 Dec 2019"},{"issue":"2","key":"5699_CR15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/cncr.26294","volume":"118","author":"MD Schwartz","year":"2012","unstructured":"Schwartz MD, Isaacs C, Graves KD, Poggi E, Peshkin BN, Gell C, Finch C, Kelly S, Taylor KL, Perley L (2012) Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance. Cancer 118(2):510\u2013517. https:\/\/doi.org\/10.1002\/cncr.26294","journal-title":"Cancer"},{"issue":"2","key":"5699_CR16","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","volume":"132","author":"C Garcia","year":"2014","unstructured":"Garcia C, Wendt J, Lyon L, Jones J, Littell RD, Armstrong MA, Raine-Bennett T, Powell CB (2014) Risk management options elected by women after testing positive for a BRCA mutation. Gynecol Oncol 132(2):428\u2013433. https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.014","journal-title":"Gynecol Oncol"},{"issue":"6","key":"5699_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/10463356.2018.1525993","volume":"33","author":"T Pal","year":"2018","unstructured":"Pal T, Radford C, Weidner A, Tezak AL, Cragun D, Wiesner GL (2018) The Inherited cancer registry (ICARE) initiative: an academic-community partnership for patients and providers. Oncol Oncology Issues 33(6):54\u201363","journal-title":"Oncol Oncology Issues"},{"issue":"13","key":"5699_CR18","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1002\/cncr.30621","volume":"123","author":"D Cragun","year":"2017","unstructured":"Cragun D, Weidner A, Lewis C, Bonner D, Kim J, Vadaparampil ST, Pal T (2017) Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors. Cancer 123(13):2497\u20132505. https:\/\/doi.org\/10.1002\/cncr.30621","journal-title":"Cancer"},{"issue":"11","key":"5699_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/humu.20415","volume":"27","author":"JL Bernstein","year":"2006","unstructured":"Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, Giles GG, Hopper JL, Concannon P (2006) Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T%3eG and c.1066-6T%3eG (IVS10-6T%3eG) from the breast cancer family registry. Hum Mutat 27(11):1122\u20131128. https:\/\/doi.org\/10.1002\/humu.20415","journal-title":"Hum Mutat"},{"issue":"4","key":"5699_CR20","doi-asserted-by":"publisher","first-page":"R73","DOI":"10.1186\/bcr2919","volume":"13","author":"DE Goldgar","year":"2011","unstructured":"Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, Andrulis I, John EM, Khanna KK, Hopper JL, Oefner PJ, Lakhani S, Chenevix-Trench G (2011) Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Res 13(4):R73. https:\/\/doi.org\/10.1186\/bcr2919","journal-title":"Breast Cancer Res"},{"key":"5699_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/108107396127988","volume":"1","author":"K Witte","year":"1996","unstructured":"Witte K, Cameron KA, McKeon JK, Berkowitz JM (1996) Predicting risk behaviors: development and validation of a diagnostic scale. J Health Commun 1:317\u2013341. https:\/\/doi.org\/10.1080\/108107396127988","journal-title":"J Health Commun"},{"key":"5699_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.9734\/BJAST\/2015\/14975","volume":"7","author":"A Joshi","year":"2015","unstructured":"Joshi A, Kale S, Chandel S, Pal DK (2015) Likert Scale: explored and explained. Br J Appl Sci Technol 7:396\u2013403","journal-title":"Br J Appl Sci Technol"},{"issue":"1","key":"5699_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10897-016-9981-6","volume":"26","author":"AH Buchanan","year":"2017","unstructured":"Buchanan AH, Voils CI, Schildkraut JM, Fine C, Horick NK, Marcom PK, Wiggins K, Skinner CS (2017) Adherence to recommended risk management among unaffected women with a BRCA mutation. J Genet Couns 26(1):79\u201392. https:\/\/doi.org\/10.1007\/s10897-016-9981-6","journal-title":"J Genet Couns"},{"issue":"3","key":"5699_CR24","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/cncr.32572","volume":"126","author":"V Vysotskaia","year":"2019","unstructured":"Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K (2019) Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations. Cancer 126(3):549\u2013558. https:\/\/doi.org\/10.1002\/cncr.32572","journal-title":"Cancer"},{"issue":"4","key":"5699_CR25","doi-asserted-by":"publisher","first-page":"e196400","DOI":"10.1001\/jamaoncol.2019.6400","volume":"6","author":"AW Kurian","year":"2020","unstructured":"Kurian AW, Ward KC, Abrahamse P, Hamilton AS, Deapen D, Morrow M, Jagsi R, Katz SJ (2020) Association of germline genetic testing results with locoregional and systemic therapy in patients with breast cancer. JAMA Oncol 6(4):e196400. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6400","journal-title":"JAMA Oncol"},{"key":"5699_CR26","unstructured":"MyGeneCounsel (2019) White paper: how often do medical management guidelines change for people with germline genetic findings? A solution for keeping patients and providers updated. https:\/\/www.mygenecounsel.com\/wp-content\/uploads\/2019\/10\/How-Often-Do-Medical-Management-Guidelines-Change.pdf?utm_source=mailchimp&utm_campaign=0300b2cee1f0&utm_medium=page. Accessed 10 Dec 2019"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05699-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-020-05699-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05699-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T23:29:35Z","timestamp":1621639775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-020-05699-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5699"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05699-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"8 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The methodology for this study was approved by the Institutional Review Boards at Vanderbilt University (IRB # 180420) and the University of South Florida (IRB # Pro00037381). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}